APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Nuclear Medicines

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Selected research

Industry Growth & Trends

Global Therapeutic Nuclear Medicines Industry Growth and Trends Forecast to 2032

21 December 2025104 pages

Choose your research edition.

Industry ResearchTherapeutic Nuclear Medicines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Nuclear Medicines Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Therapeutic Nuclear Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Nuclear Medicines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Nuclear Medicines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.

Read the full market overview

North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Nuclear Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Nuclear Medicines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Nuclear Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toTherapeutic Nuclear Medicines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Therapeutic Nuclear Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Nuclear Medicines Market by Company

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Therapeutic Nuclear Medicines Segment by Type

Radium-223

Lutetium-177

Iodine-131

Other

Therapeutic Nuclear Medicines Segment by Application

Thyroid

Bone Metastasis

Lymphoma

Other

Therapeutic Nuclear Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Nuclear Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Therapeutic Nuclear Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Radium-223 Table 2. Major Company of Lutetium-177 Table 3. Major Company of Iodine-131 Table 4. Major Company of Other Table 5. Global Therapeutic Nuclear Medicines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 7. Global Therapeutic Nuclear Medicines Sales Market Share in Volume by Type (2021-2026) Table 8. Global Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 9. Global Therapeutic Nuclear Medicines Sales Market Share in Value by Type (2021-2026) Table 10. Global Therapeutic Nuclear Medicines Price by Type (2021-2026) & (USD/unit) Table 11. Global Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 12. Global Therapeutic Nuclear Medicines Sales Market Share in Volume by Type (2027-2032) Table 13. Global Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (US$ Million) Table 14. Global Therapeutic Nuclear Medicines Sales Market Share in Value by Type (2027-2032) Table 15. Global Therapeutic Nuclear Medicines Price by Type (2027-2032) & (USD/unit) Table 16. North America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 17. North America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 19. Europe Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 23. Latin America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (US$ Million) Table 26. Therapeutic Nuclear Medicines Industry Trends Table 27. Therapeutic Nuclear Medicines Industry Drivers Table 28. Therapeutic Nuclear Medicines Industry Opportunities and Challenges Table 29. Therapeutic Nuclear Medicines Industry Restraints Table 30. Global Therapeutic Nuclear Medicines Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2021-2026) Table 32. Global Therapeutic Nuclear Medicines Sales by Company (2021-2026) & (k units) Table 33. Global Therapeutic Nuclear Medicines Sales Share by Company (2021-2026) Table 34. Global Therapeutic Nuclear Medicines Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Therapeutic Nuclear Medicines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Therapeutic Nuclear Medicines Major Company Production Sites and Headquarters Table 37. Global Therapeutic Nuclear Medicines Company, Product Type & Application Table 38. Global Therapeutic Nuclear Medicines Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Therapeutic Nuclear Medicines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Therapeutic Nuclear Medicines Sales by Region (2021-2026) & (k units) Table 43. Global Therapeutic Nuclear Medicines Sales Market Share in Volume by Region (2021-2026) Table 44. Global Therapeutic Nuclear Medicines Sales by Region (2021-2026) & (US$ Million) Table 45. Global Therapeutic Nuclear Medicines Sales Market Share in Value by Region (2021-2026) Table 46. Global Therapeutic Nuclear Medicines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Therapeutic Nuclear Medicines Sales by Region (2027-2032) & (k units) Table 48. Global Therapeutic Nuclear Medicines Sales Market Share in Volume by Region (2027-2032) Table 49. Global Therapeutic Nuclear Medicines Sales by Region (2027-2032) & (US$ Million) Table 50. Global Therapeutic Nuclear Medicines Sales Market Share in Value by Region (2027-2032) Table 51. Global Therapeutic Nuclear Medicines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Therapeutic Nuclear Medicines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 54. Global Therapeutic Nuclear Medicines Sales Market Share in Volume by Application (2021-2026) Table 55. Global Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 56. Global Therapeutic Nuclear Medicines Sales Market Share in Value by Application (2021-2026) Table 57. Global Therapeutic Nuclear Medicines Price by Application (2021-2026) & (USD/unit) Table 58. Global Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 59. Global Therapeutic Nuclear Medicines Sales Market Share in Volume by Application (2027-2032) Table 60. Global Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (US$ Million) Table 61. Global Therapeutic Nuclear Medicines Sales Market Share in Value by Application (2027-2032) Table 62. Global Therapeutic Nuclear Medicines Price by Application (2027-2032) & (USD/unit) Table 63. North America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 64. North America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 66. Europe Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 70. Latin America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Novartis AG Therapeutic Nuclear Medicines Product Portfolio Table 77. Novartis AG Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Bayer Therapeutic Nuclear Medicines Product Portfolio Table 82. Bayer Recent Development Table 83. China Isotope & Radiation Company Information Table 84. China Isotope & Radiation Business Overview Table 85. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio Table 87. China Isotope & Radiation Recent Development Table 88. Q BioMed Company Information Table 89. Q BioMed Business Overview Table 90. Q BioMed Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Q BioMed Therapeutic Nuclear Medicines Product Portfolio Table 92. Q BioMed Recent Development Table 93. Curium Pharmaceuticals Company Information Table 94. Curium Pharmaceuticals Business Overview Table 95. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio Table 97. Curium Pharmaceuticals Recent Development Table 98. Jubilant DraxImage Company Information Table 99. Jubilant DraxImage Business Overview Table 100. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio Table 102. Jubilant DraxImage Recent Development Table 103. Dongcheng Company Information Table 104. Dongcheng Business Overview Table 105. Dongcheng Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Dongcheng Therapeutic Nuclear Medicines Product Portfolio Table 107. Dongcheng Recent Development Table 108. Lantheus Company Information Table 109. Lantheus Business Overview Table 110. Lantheus Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Lantheus Therapeutic Nuclear Medicines Product Portfolio Table 112. Lantheus Recent Development Table 113. Acrotech Biopharma. Company Information Table 114. Acrotech Biopharma. Business Overview Table 115. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio Table 117. Acrotech Biopharma. Recent Development Table 118. Progenics Pharmaceuticals Company Information Table 119. Progenics Pharmaceuticals Business Overview Table 120. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio Table 122. Progenics Pharmaceuticals Recent Development Table 123. International Isotopes Company Information Table 124. International Isotopes Business Overview Table 125. International Isotopes Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. International Isotopes Therapeutic Nuclear Medicines Product Portfolio Table 127. International Isotopes Recent Development Table 128. North America Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. North America Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 130. North America Therapeutic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 131. North America Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 132. North America Therapeutic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 133. North America Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Therapeutic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Therapeutic Nuclear Medicines Market Share by Country (2021-2026) Table 136. North America Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Therapeutic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 138. Europe Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Europe Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 140. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 141. Europe Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 142. Europe Therapeutic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Therapeutic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Therapeutic Nuclear Medicines Market Share by Country (2021-2026) Table 146. Europe Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Therapeutic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 150. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 152. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Therapeutic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Therapeutic Nuclear Medicines Market Share by Country (2021-2026) Table 156. Asia-Pacific Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Therapeutic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 158. Latin America Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Latin America Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 160. Latin America Therapeutic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 161. Latin America Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 162. Latin America Therapeutic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Therapeutic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Therapeutic Nuclear Medicines Market Share by Country (2021-2026) Table 166. Latin America Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Therapeutic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 170. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032) & (k units) Table 172. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Therapeutic Nuclear Medicines Market Share by Country (2021-2026) Table 176. Middle East and Africa Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Therapeutic Nuclear Medicines Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Therapeutic Nuclear Medicines Distributors List Table 181. Therapeutic Nuclear Medicines Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Therapeutic Nuclear Medicines Image Figure 2. Global Therapeutic Nuclear Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Nuclear Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Nuclear Medicines Sales (2021-2032) & (k units) Figure 5. Radium-223 Image Figure 6. Global Radium-223 Sales YoY Growth (2021-2032) & (k units) Figure 7. Lutetium-177 Image Figure 8. Global Lutetium-177 Sales YoY Growth (2021-2032) & (k units) Figure 9. Iodine-131 Image Figure 10. Global Iodine-131 Sales YoY Growth (2021-2032) & (k units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Therapeutic Nuclear Medicines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Therapeutic Nuclear Medicines Market Share by Type 2025 VS 2032 Figure 15. North America Therapeutic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 16. North America Therapeutic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 17. Europe Therapeutic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 18. Europe Therapeutic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 21. Latin America Therapeutic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Therapeutic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Therapeutic Nuclear Medicines Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Thyroid Image Figure 28. Global Thyroid Sales YoY Growth (2021-2032) & (k units) Figure 29. Bone Metastasis Image Figure 30. Global Bone Metastasis Sales YoY Growth (2021-2032) & (k units) Figure 31. Lymphoma Image Figure 32. Global Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Therapeutic Nuclear Medicines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Therapeutic Nuclear Medicines Market Share by Application 2025 VS 2032 Figure 37. North America Therapeutic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 38. North America Therapeutic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 39. Europe Therapeutic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 40. Europe Therapeutic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 43. Latin America Therapeutic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Therapeutic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share in Value by Application in 2025 Figure 47. North America Therapeutic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Therapeutic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Therapeutic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Therapeutic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Therapeutic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Therapeutic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Therapeutic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Therapeutic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Therapeutic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Therapeutic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Therapeutic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Therapeutic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Therapeutic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Therapeutic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Therapeutic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Therapeutic Nuclear Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Therapeutic Nuclear Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Therapeutic Nuclear Medicines Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Therapeutic Nuclear Medicines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Applications
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
Companies covered
  • Novartis AG
  • Bayer
  • China Isotope & Radiation
  • Q BioMed
  • Curium Pharmaceuticals
  • Jubilant DraxImage
  • Dongcheng
  • Lantheus
  • Acrotech Biopharma.
  • Progenics Pharmaceuticals
  • International Isotopes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Therapeutic Nuclear Medicines Market by Type
  6. 1.3.1 Radium-223
  7. 1.3.2 Lutetium-177
  8. 1.3.3 Iodine-131
  9. 1.3.4 Other
  10. 1.4 Global Therapeutic Nuclear Medicines Market Size by Type
  11. 1.4.1 Global Therapeutic Nuclear Medicines Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Therapeutic Nuclear Medicines Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Therapeutic Nuclear Medicines Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Therapeutic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Therapeutic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Therapeutic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Therapeutic Nuclear Medicines Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Therapeutic Nuclear Medicines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Therapeutic Nuclear Medicines Industry Trends
  2. 2.2 Therapeutic Nuclear Medicines Industry Drivers
  3. 2.3 Therapeutic Nuclear Medicines Industry Opportunities and Challenges
  4. 2.4 Therapeutic Nuclear Medicines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Therapeutic Nuclear Medicines Revenue (2021-2026)
  2. 3.2 Global Top Players by Therapeutic Nuclear Medicines Sales (2021-2026)
  3. 3.3 Global Top Players by Therapeutic Nuclear Medicines Price (2021-2026)
  4. 3.4 Global Therapeutic Nuclear Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Nuclear Medicines Major Company Production Sites & Headquarters
  6. 3.6 Global Therapeutic Nuclear Medicines Company, Product Type & Application
  7. 3.7 Global Therapeutic Nuclear Medicines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Nuclear Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Nuclear Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Nuclear Medicines Tier 1, Tier 2, and Tier 3
4 Therapeutic Nuclear Medicines Regional Status and Outlook
  1. 4.1 Global Therapeutic Nuclear Medicines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Therapeutic Nuclear Medicines Historic Market Size by Region
  3. 4.2.1 Global Therapeutic Nuclear Medicines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Therapeutic Nuclear Medicines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Therapeutic Nuclear Medicines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Therapeutic Nuclear Medicines Forecasted Market Size by Region
  7. 4.3.1 Global Therapeutic Nuclear Medicines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Therapeutic Nuclear Medicines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Therapeutic Nuclear Medicines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Therapeutic Nuclear Medicines by Application
  1. 5.1 Therapeutic Nuclear Medicines Market by Application
  2. 5.1.1 Thyroid
  3. 5.1.2 Bone Metastasis
  4. 5.1.3 Lymphoma
  5. 5.1.4 Other
  6. 5.2 Global Therapeutic Nuclear Medicines Market Size by Application
  7. 5.2.1 Global Therapeutic Nuclear Medicines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Therapeutic Nuclear Medicines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Therapeutic Nuclear Medicines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Therapeutic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Therapeutic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Therapeutic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Therapeutic Nuclear Medicines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Therapeutic Nuclear Medicines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 China Isotope & Radiation
  14. 6.3.1 China Isotope & Radiation Company Information
  15. 6.3.2 China Isotope & Radiation Business Overview
  16. 6.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
  18. 6.3.5 China Isotope & Radiation Recent Developments
  19. 6.4 Q BioMed
  20. 6.4.1 Q BioMed Company Information
  21. 6.4.2 Q BioMed Business Overview
  22. 6.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
  24. 6.4.5 Q BioMed Recent Developments
  25. 6.5 Curium Pharmaceuticals
  26. 6.5.1 Curium Pharmaceuticals Company Information
  27. 6.5.2 Curium Pharmaceuticals Business Overview
  28. 6.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
  30. 6.5.5 Curium Pharmaceuticals Recent Developments
  31. 6.6 Jubilant DraxImage
  32. 6.6.1 Jubilant DraxImage Company Information
  33. 6.6.2 Jubilant DraxImage Business Overview
  34. 6.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
  36. 6.6.5 Jubilant DraxImage Recent Developments
  37. 6.7 Dongcheng
  38. 6.7.1 Dongcheng Company Information
  39. 6.7.2 Dongcheng Business Overview
  40. 6.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
  42. 6.7.5 Dongcheng Recent Developments
  43. 6.8 Lantheus
  44. 6.8.1 Lantheus Company Information
  45. 6.8.2 Lantheus Business Overview
  46. 6.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
  48. 6.8.5 Lantheus Recent Developments
  49. 6.9 Acrotech Biopharma.
  50. 6.9.1 Acrotech Biopharma. Company Information
  51. 6.9.2 Acrotech Biopharma. Business Overview
  52. 6.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
  54. 6.9.5 Acrotech Biopharma. Recent Developments
  55. 6.10 Progenics Pharmaceuticals
  56. 6.10.1 Progenics Pharmaceuticals Company Information
  57. 6.10.2 Progenics Pharmaceuticals Business Overview
  58. 6.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
  60. 6.10.5 Progenics Pharmaceuticals Recent Developments
  61. 6.11 International Isotopes
  62. 6.11.1 International Isotopes Company Information
  63. 6.11.2 International Isotopes Business Overview
  64. 6.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
  66. 6.11.5 International Isotopes Recent Developments
7 North America by Country
  1. 7.1 North America Therapeutic Nuclear Medicines Sales by Country
  2. 7.1.1 North America Therapeutic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Therapeutic Nuclear Medicines Sales by Country (2021-2026)
  4. 7.1.3 North America Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Therapeutic Nuclear Medicines Market Size by Country
  6. 7.2.1 North America Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Therapeutic Nuclear Medicines Market Size by Country (2021-2026)
  8. 7.2.3 North America Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Therapeutic Nuclear Medicines Sales by Country
  2. 8.1.1 Europe Therapeutic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Therapeutic Nuclear Medicines Sales by Country (2021-2026)
  4. 8.1.3 Europe Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Therapeutic Nuclear Medicines Market Size by Country
  6. 8.2.1 Europe Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Therapeutic Nuclear Medicines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Therapeutic Nuclear Medicines Sales by Country
  2. 9.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Therapeutic Nuclear Medicines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Therapeutic Nuclear Medicines Market Size by Country
  6. 9.2.1 Asia-Pacific Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Therapeutic Nuclear Medicines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Therapeutic Nuclear Medicines Sales by Country
  2. 10.1.1 South America Therapeutic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Therapeutic Nuclear Medicines Sales by Country (2021-2026)
  4. 10.1.3 South America Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Therapeutic Nuclear Medicines Market Size by Country
  6. 10.2.1 South America Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Therapeutic Nuclear Medicines Market Size by Country (2021-2026)
  8. 10.2.3 South America Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country
  2. 11.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Therapeutic Nuclear Medicines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country
  6. 11.2.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Therapeutic Nuclear Medicines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Therapeutic Nuclear Medicines Value Chain Analysis
  2. 12.1.1 Therapeutic Nuclear Medicines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Therapeutic Nuclear Medicines Production Mode & Process
  7. 12.2 Therapeutic Nuclear Medicines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Therapeutic Nuclear Medicines Distributors
  10. 12.2.3 Therapeutic Nuclear Medicines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst